Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Cardiology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
MAPLE-HCM: Aficamten vs Metoprolol in Obstructive HCM
4
Mins
October 2025
Beta-blockers have been the cornerstone of treatment for obstructive hypertrophic cardiomyopathy for almost 6 years. Recent data from…
Read more
4
Mins
9 Oct 2025
MAPLE-HCM: Aficamten vs Metoprolol in Obstructive HCM
Beta-blockers have been the cornerstone of treatment for obstructive hypertrophic cardiomyopathy for almost 6 years. Recent data from…
4
Mins
9 Oct 2025
SGLT2 Inhibitors in Heart Failure: Why the Elderly are Missing Out
Heart failure (HF) constitutes a significant disease burden in the USA. Its prevalence has doubled between 1990–2020, showing an increase…
7
Mins
2 Oct 2025
Simplified Approach to PCI for Bifurcation Lesions
Coronary bifurcation lesions pose a significant challenge in interventional cardiology, accounting for approximately 15–25% of…
10
Mins
25 Sep 2025
EDG-7500 in Hypertrophic Cardiomyopathy
Michelle Michels and Perry Elliott discuss the CIRRUS-HCM study of EDG-7500 in hypertrophic cardiomyopathy, highlighting clinical benefits…
5
Mins
23 Sep 2025
Beyond the Glass Ceiling: Interview with Cathleen Biga
I think what we have discovered post-COVID-19 is that cardiology is a team sport and caring for today’s patient population…
7
Mins
22 Sep 2025
Unrepaired TOF with Pulmonary Atresia and MAPCA in Pregnancy
Tetralogy of Fallot (TOF) is one of the most common forms of cyanotic congenital heart disease, characterised by…
7
Mins
22 Sep 2025
Rethinking Heart Failure Care: Interview with Nancy Sweitzer
What first drew me to cardiology, and then to heart failure, was the ability to treat people and make them feel better…
4
Mins
11 Sep 2025
Renal Angioplasty and Stenting for Atherosclerotic Renal Artery Stenosis
Renal artery stenosis (RAS), which is most often atherosclerotic in aetiology (90% of cases), remains a contentious indication for…
Loading posts...
1
2
3
…
26
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View